A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension
Stopped The pivotal study, BPS-314d-MR-PAH-302 (NCT01908699), failed to demonstrate efficacy.
Conditions
- Pulmonary Arterial Hypertension
Interventions
- DRUG: Esuberaprost
- DRUG: Placebo
Sponsor
Lung Biotechnology PBC